These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 28294054)
1. Recent Advances in Preclinical Studies and Potential Applications of Dendrimers as Drug Carriers in the Central Nervous System. Gagliardi M Curr Pharm Des; 2017; 23(21):3105-3119. PubMed ID: 28294054 [TBL] [Abstract][Full Text] [Related]
3. Dendrimer advances for the central nervous system delivery of therapeutics. Xu L; Zhang H; Wu Y ACS Chem Neurosci; 2014 Jan; 5(1):2-13. PubMed ID: 24274162 [TBL] [Abstract][Full Text] [Related]
4. PAMAM Dendrimers Cross the Blood-Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice. Srinageshwar B; Peruzzaro S; Andrews M; Johnson K; Hietpas A; Clark B; McGuire C; Petersen E; Kippe J; Stewart A; Lossia O; Al-Gharaibeh A; Antcliff A; Culver R; Swanson D; Dunbar G; Sharma A; Rossignol J Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335421 [TBL] [Abstract][Full Text] [Related]
5. Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier. Hemmer R; Hall A; Spaulding R; Rossow B; Hester M; Caroway M; Haskamp A; Wall S; Bullen HA; Morris C; Haik KL Molecules; 2013 Sep; 18(9):11537-52. PubMed ID: 24048286 [TBL] [Abstract][Full Text] [Related]
6. Dendrimers as vectors for genetic material delivery to the nervous system. Pérez-Martínez FC; Ocaña AV; Pérez-Carrión MD; Ceña V Curr Med Chem; 2012; 19(29):5101-8. PubMed ID: 22963638 [TBL] [Abstract][Full Text] [Related]
7. Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model. Sharma A; Porterfield JE; Smith E; Sharma R; Kannan S; Kannan RM J Control Release; 2018 Aug; 283():175-189. PubMed ID: 29883694 [TBL] [Abstract][Full Text] [Related]
9. Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Kitchens KM; El-Sayed ME; Ghandehari H Adv Drug Deliv Rev; 2005 Dec; 57(15):2163-76. PubMed ID: 16289433 [TBL] [Abstract][Full Text] [Related]
10. Polymer Nanoparticles as Smart Carriers for the Enhanced Release of Therapeutic Agents to the CNS. Gagliardi M; Borri C Curr Pharm Des; 2017; 23(3):393-410. PubMed ID: 27799038 [TBL] [Abstract][Full Text] [Related]
11. Size and Surface Charge of Engineered Poly(amidoamine) Dendrimers Modulate Tumor Accumulation and Penetration: A Model Study Using Multicellular Tumor Spheroids. Bugno J; Hsu HJ; Pearson RM; Noh H; Hong S Mol Pharm; 2016 Jul; 13(7):2155-63. PubMed ID: 26828309 [TBL] [Abstract][Full Text] [Related]
12. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma. Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456 [TBL] [Abstract][Full Text] [Related]
13. Dendrimer-mediated approaches for the treatment of brain tumor. Dwivedi N; Shah J; Mishra V; Mohd Amin MC; Iyer AK; Tekade RK; Kesharwani P J Biomater Sci Polym Ed; 2016; 27(7):557-80. PubMed ID: 26928261 [TBL] [Abstract][Full Text] [Related]
14. Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain. Beg S; Samad A; Alam MI; Nazish I CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):576-88. PubMed ID: 21631401 [TBL] [Abstract][Full Text] [Related]
15. A Robust Intrinsically Green Fluorescent Poly(Amidoamine) Dendrimer for Imaging and Traceable Central Nervous System Delivery in Zebrafish. Wang G; Zhao X; Wu H; Lovejoy DB; Zheng M; Lee A; Fu L; Miao K; An Y; Sayyadi N; Ding K; Chung RS; Lu Y; Li J; Morsch M; Shi B Small; 2020 Oct; 16(39):e2003654. PubMed ID: 32875740 [TBL] [Abstract][Full Text] [Related]
16. Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers. Kojima C; Regino C; Umeda Y; Kobayashi H; Kono K Int J Pharm; 2010 Jan; 383(1-2):293-6. PubMed ID: 19761822 [TBL] [Abstract][Full Text] [Related]
17. Dendrimer technologies for brain tumor. Mishra V; Kesharwani P Drug Discov Today; 2016 May; 21(5):766-78. PubMed ID: 26891979 [TBL] [Abstract][Full Text] [Related]
18. In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry. Albertazzi L; Gherardini L; Brondi M; Sulis Sato S; Bifone A; Pizzorusso T; Ratto GM; Bardi G Mol Pharm; 2013 Jan; 10(1):249-60. PubMed ID: 23163881 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin. Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583 [TBL] [Abstract][Full Text] [Related]
20. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery. Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]